Formulation and Evaluation of Transdermal Patch of Repaglinide
Open Access
- 20 July 2011
- journal article
- Published by Hindawi Limited in ISRN Pharmaceutics
- Vol. 2011, 1-9
Abstract
Repaglinide has the half life of 1 hour, and bioavailability in the body is 56% due to first-pass metabolism. The total daily dose of Repaglinide is 16 mg (e.g., 4 mg four times daily depending on meal patterns); hence, it required frequent dosing. Transdermal patch of Repaglinide was prepared to sustain the release and improve bioavailability of drug and patient compliance. Different formulations were prepared by varying the grades of HPMC and concentration of PVP K30 by solvent casting method. The prepared formulations were evaluated for various parameters like thickness, tensile strength, folding endurance, % elongation, % moisture content, % moisture uptake, % drug content, in vitro drug release, in vitro permeation, and drug excipient compatibility. A 32 full factorial design was applied to check the effect of varying the grades of HPMC () and PVP concentration () on the responses, that is, tensile strength, percentage drug released in 1 hr (), 9 hr (), and diffusion coefficient as a dependent variables. In vitro release data were fitted to various models to ascertain kinetic of drug release. Regression analysis and analysis of variance were performed for dependent variables. The results of the F2 statistics between factorial design batches and theoretical profile were used to select optimized batch. Batch F6 was considered optimum batch which contained HPMC K100 and PVP (1.5%), showed release 92.343% up to 12 hr, and was more similar to the theoretical predicted dissolution profile ().
Keywords
This publication has 7 references indexed in Scilit:
- SYNOPSIS OF MEDICAL STATISTICS: From Wikipedia, the free encyclopedia.2008
- Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)Advanced Drug Delivery Reviews, 2001
- Effect of Penetration Enhancers on the in Vitro Transport of Ephedrine Through Rat Skin and Human Epidermis from Matrix Based Transdermal FormulationsDrug Development and Industrial Pharmacy, 1993
- One-way membrane for transdermal drug delivery systems. II. System optimizationInternational Journal of Pharmaceutics, 1991
- Mechanisms of solute release from porous hydrophilic polymersInternational Journal of Pharmaceutics, 1983
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963
- Dependence of Reaction Velocity upon surface and AgitationIndustrial & Engineering Chemistry, 1931